Overview
- Head Office
- 3-4-10, Shinsuna, Koto-ku, Tokyo
136-0075
Tel 03-5634-7006 - Purposes
- Research, development, manufacture, sale, purchase and import/export of radioactive pharmaceuticals, as well as radioactive medical devices and their related products
- Incorporation
- March 20,1973
- Capital
- 3,145,780 thousand yen
- Shareholders
- Sumitomo Chemical Co., Ltd. 50%
GE Healthcare 50% - Customers
- Major hospitals throughout Japan
- Banks
- Sumitomo Mitsui Banking Corporation
Sumitomo Mitsui Trust Bank, Limited - Sales
- 28.2 billion yen in the fiscal year 2023
- Number of Employees
- 784（as of March 2024）
- Affiliated Company
- NMP Business Support Co., Ltd.
![[New window]](/sites/default/images/corpo/common/img/icon/window-02.png)
Head office
For inquiry
- General Affairs Dept.
- Tel 03-5634-7006
- Research Centre
- Tel 0438-62-7611
Management Line-up
(As of July 2024)
- Representative Director President
- Yoshitaka Tomigahara
- Representative Director
(Non-executive) - Kevin O'Neill
- DirectorExecutive Vice President
- Yoshinori Wakatsuki
- Director
(Non-executive) - Hiroshi Ueda
- Director
(Non-executive) - Noriaki Takeshita
- Director
(Non-executive) - Yuji Kato
- Director
(Non-executive) - Julia Casey
- Director
(Non-executive) - Emi Fukutome
- Executive Officer
- Masahiro Takayama
- Executive Officer
- Shinichi Ota
- Executive Officer
- Nobuyuki Takahashi
- Executive Officer
- Tatsuo Kato
- Executive Officer
- Tadashi Hatano
- Executive Officer
- Hirofumi Taniguchi
- Standing Corporate Auditor
- Toshio Iguchi
- Corporate Auditor
- Yasuhiro Kawakami
- Corporate Auditor
- Miki Usuki
